Concepedia

Author

Thomas Kryza

Translational Research InstituteORCID

Also Known As

Kryza, T., T. Kryza, Thomas Kryza

67

Publications

1.1K

Citations

19

H-Index

38

Concepts

All Affiliations

Translational Research InstituteQueensland University of TechnologyThe University of QueenslandMater ResearchUniversité de Tours
TK

About

Thomas Kryza is an author at Translational Research Institute specializing in medicine, pharmacology, and engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

125

2

Engineering

2

2

83

3

Natural Sciences

2

2

46

4

Biochemistry

1

1

25

5

Biomedical Engineering

1

1

47

Thomas Kryza

×

23

Publications

605

Citations

16

H-Index

YearCitations

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis

Emilie Dalloneau, Nadine Baroukh, Konstantinos Mavridis,

Oncotarget

2016

48

GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids

Nathalie Bock, Farzaneh Forouz, Luke Hipwood,

Pharmaceutics

2023

47

Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment

Nathalie Bock, Ali Shokoohmand, Thomas Kryza,

Bone Research

2019

42

In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer

Nathalie Bock, Thomas Kryza, Ali Shokoohmand,

Science Advances

2021

42

The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer

Thomas Kryza, Nathalie Bock, S. Lovell,

Molecular Oncology

2019

39

Angiogenesis stimulated by human kallikrein‐related peptidase 12 acting <i>via</i> a platelet‐derived growth factor B‐dependent paracrine pathway

Thomas Kryza, Carole Achard, Christelle Parent,

The FASEB Journal

2013

37

First-in-Human<sup>212</sup>Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer

Matthew R. Griffiths, David A. Pattison, Melissa J. Latter,

Journal of Nuclear Medicine

2024

36

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors

Florence Brellier, Enrico Martina, Martin Degen,

BMC Clinical Pathology

2012

35

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma

Thomas Kryza, Tashbib Khan, Simon Puttick,

Theranostics

2020

32

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome

Lakmali M. Silva, Thomas Kryza, Thomas Stoll,

Molecular & Cellular Proteomics

2019

30

Page 1